These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33721346)

  • 1. An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata.
    Glickman JW; Dubin C; Dahabreh D; Han J; Del Duca E; Estrada YD; Zhang N; Kimmel GW; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    Allergy; 2021 Oct; 76(10):3053-3065. PubMed ID: 33721346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
    Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
    Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement.
    Dubin C; Glickman JW; Del Duca E; Chennareddy S; Han J; Dahabreh D; Estrada YD; Zhang N; Kimmel GW; Singer G; Chowdhury M; Zheng AY; Angelov M; Gay-Mimbrera J; Ruano Ruiz J; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2022 Mar; 86(3):551-562. PubMed ID: 34044102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment.
    Fuentes-Duculan J; Gulati N; Bonifacio KM; Kunjravia N; Zheng X; Suárez-Fariñas M; Shemer A; Guttman-Yassky E; Krueger JG
    Exp Dermatol; 2016 Apr; 25(4):282-6. PubMed ID: 26661294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
    Renert-Yuval Y; Pavel AB; Del Duca E; Facheris P; Pagan AD; Bose S; Gómez-Arias PJ; Angelov M; Bares J; Chima M; Estrada YD; Garcet S; Lebwohl MG; Krueger JG; Guttman-Yassky E
    Allergy; 2023 Apr; 78(4):1047-1059. PubMed ID: 36271804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds.
    Kim M; Del Duca E; Dahabreh D; Lozano-Ojalvo D; Carroll B; Manson M; Bose S; Gour D; NandyMazumdar M; Liu Y; Yu Ekey M; Chowdhury A; Angelov M; Ungar B; Estrada Y; Guttman-Yassky E
    Allergy; 2024 Aug; ():. PubMed ID: 39115359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers.
    Guttman-Yassky E; Pavel AB; Diaz A; Zhang N; Del Duca E; Estrada Y; King B; Banerjee A; Banfield C; Cox LA; Dowty ME; Page K; Vincent MS; Zhang W; Zhu L; Peeva E
    J Allergy Clin Immunol; 2022 Apr; 149(4):1318-1328. PubMed ID: 34863853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in alopecia Areata: A systematic review and meta-analysis.
    Zaaroura H; Gilding AJ; Sibbald C
    Autoimmun Rev; 2023 Jul; 22(7):103339. PubMed ID: 37087083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.
    Czarnowicki T; He HY; Wen HC; Hashim PW; Nia JK; Malik K; Estrada Y; Kimmel GW; Taliercio M; Krueger JG; Guttman-Yassky E
    Allergy; 2018 Mar; 73(3):713-723. PubMed ID: 29083474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
    Elmaadawy E; Elgarhy LH; Shareef M
    J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory Vδ1
    Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
    J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata.
    Gautam RK; Singh Y; Gupta A; Arora P; Khurana A; Chitkara A
    J Cosmet Dermatol; 2020 Jan; 19(1):234-240. PubMed ID: 31087753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing.
    Del Duca E; Ruano Ruiz J; Pavel AB; Sanyal RD; Song T; Gay-Mimbrera J; Zhang N; Estrada YD; Peng X; Renert-Yuval Y; Phelps RG; Paus R; Krueger JG; Guttman-Yassky E
    Br J Dermatol; 2020 Dec; 183(6):1083-1093. PubMed ID: 32215911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata severity index (AASI): A reliable scoring system to assess the severity of alopecia areata on face and scalp-a pilot study.
    Majid I; Sameem F; Sultan J; Aleem S
    J Cosmet Dermatol; 2021 Aug; 20(8):2565-2570. PubMed ID: 34129730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
    Renert-Yuval Y; Correa da Rosa J; Garcet S; Pavel AB; Bares J; Chima M; Hawkes JE; Gilleaudeau P; Sullivan-Whalen M; Singer GK; Krueger JG; Guttman-Yassky E
    Br J Dermatol; 2022 Oct; 187(4):539-547. PubMed ID: 35656793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Metagenomic Profiling, Urine Metabolomics, and Human Marker Gene Expression as an Integrated Approach to Study Alopecia Areata.
    Pinto D; Calabrese FM; De Angelis M; Celano G; Giuliani G; Gobbetti M; Rinaldi F
    Front Cell Infect Microbiol; 2020; 10():146. PubMed ID: 32411613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin and p53 genes in patients with alopecia areata: A case-control study.
    Marie REM; Abd El-Fadeal NM; Atef LM
    Australas J Dermatol; 2021 Feb; 62(1):e29-e34. PubMed ID: 32951213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
    He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
    J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.
    ; Moussa A; Bennett M; Wall D; Meah N; York K; Bokhari L; Asfour L; Rees H; Abraham LS; Asz-Sigall D; Basmanav FB; Bergfeld W; Betz RC; Bhoyrul B; Blume-Peytavi U; Callender V; Chitreddy V; Combalia A; Cotsarelis G; Craiglow B; Dhurat R; Donovan J; Doroshkevich A; Eisman S; Farrant P; Ferrando J; Gadzhigoroeva A; Green J; Grimalt R; Harries M; Hordinsky M; Irvine A; Jolliffe V; Kaiumov S; King B; Lee J; Lee WS; Li J; Lortkipanidze N; McMichael A; Mesinkovska NA; Messenger A; Mirmirani P; Olsen E; Orlow SJ; Ovcharenko Y; Piraccini BM; Pirmez R; Rakowska A; Reygagne P; Rudnicka L; Corralo DS; Senna M; Shapiro J; Sharma P; Siliuk T; Starace M; Suchonwanit P; Takwale A; Tosti A; Vañó-Galván S; Visser WI; Vogt A; Wade M; Yip L; Zhou C; Sinclair R
    JAMA Dermatol; 2024 Mar; 160(3):341-350. PubMed ID: 38324292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.